Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q1 2015 · 10-Q
Revenue$0.00$0.00— vs Q1 2014 Net Income-$1.37M-$1.37MN/M vs Q1 2014 EPS Diluted-$0.02-$0.02N/M vs Q1 2014 Operating Income-$1,378,893N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 11, 2015 · 41 d after period end